OneSkin raises $20m to revolutionize anti-ageing skincare
Longevity Technology - 14-Nov-2024A science-backed approach to healthier, younger-looking skin
Eleanor Garth
Staff Writer and Community Manager, Longevity Technology
Following a degree in Classics, Eleanor organised biomedical engineering conferences and provided research support at Imperial College London and various London hospitals, before working as a science and medicine journalist.
Visit website: https://www.longevity.technology/author/eleanor/
See also: 
Longevity Technology
- Daily news and insights on research, investments and technologies on life extension
Details last updated 03-Jun-2020
Eleanor Garth is also referenced in the following:
Citizens Science and Your Longevity
26-Feb-2022
Online webinar about science and longevity organized by Coalition for Radical Life Extension moderated by Dr. Greg Fahy (FREE)
Articles written by Eleanor Garth
International Institute of Longevity relaunches to set global standards for longevity clinics
Longevity Technology - 17-Oct-2024They aim to improve patient care and make clinics more trustworthy and effective
The Cat Health Company secures funding to transform feline longevity
Longevity Technology - 24-Sep-2024Innovative partnerships aim to develop groundbreaking therapeutics for age-related diseases in cats
Montara Therapeutics raises $8M to develop brain-targeted drugs
Longevity Technology - 01-Aug-2024Approach is based on research from UCSF and could transform how diseases are treated
BioXtek pioneers new regenerative therapies with human birth tissue
Longevity Technology - 17-Jul-2024Unlocks the healing power of placentas for wound care, anti-aging, and beyond
TruDiagnostic launches a novel epigenetic ageing test to analyse 11 organs
Longevity Technology - 28-Jun-2024Findings indicate that each organ system has its unique ageing trajectory
BrainBridge is working on a way to transplant a person's head onto a new body
Longevity Technology - 21-May-2024This could potentially revolutionize treatment for severe conditions
Hevolution invests $20 million in Aeovian Pharmaceuticals to fight ageing
Longevity Technology - 28-Mar-2024Funds to advance compounds that target mTORC1 pathway for treating rare and age-related conditions
SENISCA secures 3.7 million euros to fight aging with RNA-based therapies
Longevity Technology - 18-Mar-2024Developing senotherapeutics to target cellular senescence and treat age-related diseases
Tagomics secures 6.7M euros to revolutionize disease diagnosis with multiomics
Longevity Technology - 21-Feb-2024Unlocking a new era of comprehensive disease insights and treatment strategies
GlycanAge raises $4.2M to develop disease-detecting blood tests using sugar molecules
Longevity Technology - 19-Feb-2024Company aims to transform healthcare by using cutting-edge sugar-based diagnostics
Drug company BioAge raised $170 million to make new medicines for obesity
Longevity Technology - 13-Feb-2024Their main drug, azelaprag, is like a pill that mimics the benefits of exercise
L'Oréal and Nestlé invest $66M in Timeline's Mitopure technology
Longevity Technology - 17-Jan-2024Company plans to bring their revolutionary Mitopure technology to the world
$20.6 million fuels Vandria's mission to conquer ageing and chronic diseases
Longevity Technology - 14-Dec-2023Mitophagy-boosting drug candidate VNA-318 preps for clinical trials
SRW and Insilico partner to develop AI-powered nutraceuticals
Longevity Technology - 08-Nov-2023Using AI to screen natural compounds and create novel longevity products
Gero raises $6M to hack the ageing code and combat age-related diseases
Longevity Technology - 18-Oct-2023Company's quest to decode ageing and develop novel therapies gains momentum
New venture capital firm age1 aims to extend healthy lifespan
Longevity Technology - 22-Sep-2023Investing in the next generation of longevity biotech companies
Telos Biotech parent, Cambrian Bio, to develop robust cell therapies for treating age-related diseases
Longevity Technology - 27-Jun-2023Novel recombinant protein to manufacture biologically fit cells by safely lengthening telomeres
Novel heart disease treatment given $145m boost with Bitterroot Bio funding
Longevity Technology - 19-Jun-2023Biotech leverages insights from immunology and cardiology, aiming to dissolve arterial plaques with their flagship asset, BRB-002
VitaDAO provides $50,000 funding for ImmuneAGE Bio to accelerate its immune rejuvenation research
Longevity Technology - 10-May-2023Will use its drug discovery platform to further development of lead compound, IA101
Display all articles
